Cd200 tumor is becoming a potential biomarker associated with the efficacy of single therapy 23Me-00610 for 23Andme Holding Co.
23Andme Holding Co.：肿瘤 Cd200 正在成为与 23Me-00610 单一疗法功效相关的潜在生物标志物
Cd200 tumor is becoming a potential biomarker associated with the efficacy of single therapy 23Me-00610 for 23Andme Holding Co.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.